ChemicalBook CAS DataBase List 2474977-38-1

2474977-38-1

Name	Benzenesulfonamide, 4-[5-phenyl-3-[[[[4-(trifluoromethyl)phenyl]amino]carbonyl]amino]-1H-pyrazol-1-yl]-
CAS	2474977-38-1
Molecular Formula	C23H18F3N5O3S
Molecular Weight	501.48
MOL File	2474977-38-1.mol

Chemical Properties

density	1.46±0.1 g/cm3(Predicted)
pka	9.73±0.10(Predicted)

Hazard Information

Uses

COX-2/sEH-IN-1 (Compound 9c) is an orally active, dual COX-2 and sEH (soluble epoxide hydrolase) inhibitor with IC50 values of 1.24 μM and 0.40 nM against COX-2 and sEH, respectively. COX-2/sEH-IN-1 shows improved anti-inflammatory activity and highly reduced cardiovascular risks[1].

in vivo

COX-2/sEH-IN-1 (Compound 9c) (10 mg/kg; p.o.; once) exhibits analgesic activity^[1].
COX-2/sEH-IN-1 (50 mg/kg; p.o.; once) shows high anti-inflammatory activity^[1].
COX-2/sEH-IN-1 (100 mg/kg; p.o.; 2 weeks) affords a perfect cardio-protection and less cardiovascular liabilities^[1].

Animal Model:	Albino mice (20-30 g)^[1]
Dosage:	10 mg/kg
Administration:	Oral administration, once
Result:	Exhibited analgesic activity with 65.67% inhibition in the number of writhing.

Animal Model:	Albino rats (120-150 g), carrageenan-induced paw edema model^[1]
Dosage:	50 mg/kg
Administration:	Oral administration, once
Result:	Showed high anti-inflammatory activity with edema inhibition of 64.06%, 95.82%, and 98.15% at 1, 3, 5 h, respectively.

Animal Model:	Adult male albino Wister rats (170-200 g)^[1]
Dosage:	100 mg/kg
Administration:	Oral administration, 2 weeks
Result:	Exhibited a significant lowering in Troponine-I, LDH and CK-MB levels when compared to celecoxib treated group. Showed remarkably decrease in TNF-α concentration compared to the celecoxib induced cardio-toxicity group. Restored heart GSH level and significantly increased PGI2 level compared to celecoxib group. Showed mild decongestant and mild edema on cardiac blood vessels and showed more or less normal muscle bundles.

IC 50

sEH: 0.40 nM (IC₅₀); COX-2: 1.24 μM (IC₅₀); COX-1: 8.72 μM (IC₅₀)

References

[1] Ahmed H Abdelazeem, et al. Discovery of novel urea-diarylpyrazole hybrids as dual COX-2/sEH inhibitors with improved anti-inflammatory activity and highly reduced cardiovascular risks. Eur J Med Chem. 2020 Nov 1;205:112662. DOI:10.1016/j.ejmech.2020.112662

Supplier

Send Inquriy